Literature DB >> 15182054

Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.

Mara Ferrara1, Sofia M R Matarese, Barbara Borrelli, Angelo Perrotta, Gelsomina Simeone, Natalizia Greco, Diana Iarussi, Luigi Esposito.   

Abstract

The forms and severity of cardiac complications were investigated in patients with asymptomatic thalassemia intermedia and thalassemia major by M-mode, bi-dimensional echocardiography (ECHO) and echo-Doppler. Twenty-eight patients of both sexes with beta-thalassemia intermedia (beta-TI), mean age 23.2 +/- 6.3 years, untransfused or minimally transfused, were compared to 42 age- and sex-matched subjects with thalassemia major, who were regularly treated with hemotransfusive therapy [pre-transfusion hemoglobin (Hb) values 9.5 +/- 0.9 g/dL] and iron chelation. All patients were splenectomized. Age and sex matched healthy control subjects were randomly selected. beta-Thalassemia major (beta-TM) patients showed a marked reduction in contractile state and a milder left ventricular (LV) enlargement than beta-TI patients. Cardiac output (CO) and cardiac index (CI) were increased in both groups of patients but appeared significantly higher in beta-TI patients with consequent altered LV diastolic function indices. In addition, beta-TI patients had reduced indices of pulmonary artery flow related to long-term chronic anemia rather than iron overload. The progressive rise in CO and CI casts doubts on the current management of beta-TI syndromes.

Entities:  

Mesh:

Year:  2004        PMID: 15182054     DOI: 10.1081/hem-120034248

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia.

Authors:  Roya Isa Tafreshi; Mohammad Radgoodarzi; Kadijeh Arjmandi Rafsanjani; Fahimeh Soheilipour
Journal:  Front Pediatr       Date:  2022-06-17       Impact factor: 3.569

Review 2.  Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Authors:  Suree Lekawanvijit; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

3.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.